BEGIN:VCALENDAR VERSION:2.0 PRODID:-//132.216.98.100//NONSGML kigkonsult.se iCalcreator 2.20.4// BEGIN:VEVENT UID:20260415T194944EDT-5187iNJniv@132.216.98.100 DTSTAMP:20260415T234944Z DESCRIPTION:Interested in exploring careers in clinical research\, data sci ence\, consulting\, entrepreneurship within the cannabis industry?  Learn more about the range of opportunities within this emerging market.\n\nMODE RATOR:\n\nRony Chamoun\, PhD\, Academic Coordinator and Industry Liaison M anager\, Commercial Cannabis Diploma\, McGill\n\nPANELISTS:\n\nCarolyn J. Baglole\, PhD\n Director- McGill Research Centre for Cannabis\n Director- Hi stopathology Technology Platform\n Co-Director- Experimental Pathology Unit \n Associate Professor\n Departments of Medicine\, Pathology & Pharmacology & Therapeutics\n McGill University\n\nDr. Carolyn Baglole received her BSc and MSc from the University of Prince Edward Island\, and her PhD from the University of Calgary. She then did postdoctoral research in the fields o f lung biology/toxicology in the Department of Environment Medicine at the University of Rochester (Rochester NY). She is currently an Associate Pro fessor in the Departments of Pathology\, Pharmacology & Therapeutics and E xperimental Medicine at McGill University. She is the Director of the McGi ll Research Centre for Cannabis\, Co-Director of the Experimental Patholog y Unit at McGill and Co-Director of the Environment/Genetics/Cancer Axis o f the Reseau en Sante Respiratoire du Quebec.\n\nDr. Baglole’s translation al research program is designed to identify novel cellular and molecular p athways that control the pathogenesis of chronic lung diseases. Her main r esearch focus is to understand how these environmental exposures contribut e to pathogenic mechanisms such as chronic inflammation and cell death (ap optosis) that drive the development of diseases such as chronic obstructiv e pulmonary disease (COPD) and lung cancer. One of the current focuses in her lab is to understand how various forms of inhaled cannabis and/or cann abinoids affects lung and immune function. Using preclinical models of exp osure\, her team will investigate activation of cellular signaling pathway s by cannabis/cannabinoids\, how cannabis affect immune cell numbers and f unction\, whether newer forms of inhaled cannabis impact lung function and the efficacy of cannabis on disease.\n\nAntonio Vigano\, MD\, MSc\n Attend ing Physician\, Supportive and Palliative Care Division\, McGill Universit y Health Centre (MUHC)\n Associate Professor\, Department of Oncology\, McG ill University\n Director\, Cancer Rehabilitation Program (CAREPRO)\, MUHC \n Director\, McGill Nutrition and Performance Laboratory\, MUHC\n Expert on Medical Cannabis appointed by the Court of Quebec\n Research Director\, Sa nte' Cannabis (santecannabis.ca)\n\nIn 2002\, Dr. Vigano joined the Suppor tive and Palliative Care Division at McGill as Assistant Professor. He is now Associate Professor in the Department of Oncology\, Faculty of Medicin e\, McGill University. He has been practicing palliative care medicine for over 30 years both in Europe and in Canada. In 2005\, he received both th e Canadian Institutes of Health Research (CIHR) New Investigator and Fonds de la Recherche en Sante (FRSQ) Chercheur-Boursier Clinicien Career Award s. Through a Canadian Foundation for Innovation award\, he founded the McG ill Nutrition and Performance Laboratory (www.mnupal.mcgill.ca). His resea rch and clinical activities at MNUPAL were developed in partnership with t he Department of Exercise Science at Concordia University (Dr. Robert Kilg our)\, the Division of Geriatric Medicine (Dr. Jose Morais)\, and the Lymp hedema Program (Dr. Anna Towers) at McGill University Health Centre. Dr. V igano has either first or senior authorship on over 55 publications in pee r reviewed journals\, 40 invited lectures\, 115 peer-reviewed published ab stracts and four book chapters. These reflect his clinical interests and e xpertise and include: the organization of the first palliative care unit i n Italy within a public hospital\, prognostication in terminal cancer pati ents\, age-related changes in opioid consumption\, cancer cachexia assessm ent and management\, prevalence and role of hypogonadism in male cancer pa tients\, cancer pre-habilitation and rehabilitation and more recently the role of medicinal cannabis in pain and symptom management\, supportive and palliative care. Dr. Vigano was appointed Expert on Medical Cannabis by t he Court of Quebec\, created the first world-wide post-doctoral research f ellowship in medicinal cannabis and cancer supportive care within McGill’s Gerald Bronfman Department of Oncology\, developed the first cannabis cli nic within a quaternary oncology centre\, is co-lead of Biomedical Axis of the newly created McGill Research Centre for Cannabis and is Principal In vestigator in several cannabis clinical trials including the first large s cale\, province wide\, prospective\, multicenter cohort study\, the Quebec Cannabis Registry with over 3000 patients enrolled to date.\n\nCynthia El Hage\, PhD. \n Director of Research & Innovation\, Santé Cannabis\n\nI hol d a Ph.D in Neurosciences with a specialty in Mental Health and Drug Addic tion from the University of Lyon-France. I moved to Montréal in 2012 for m y postdoctoral fellowship training during which my work focused mainly on studying medical cannabis in patients suffering from psychostimulant drug abuse and co-morbid mental health disorders.  I have more than 10 years’ e xperience in research (among which 4 years experience in clinical trials a nd in medical cannabis). I have several publications in peer review journa ls\, conferences and several award winning prices related to research proj ects. I recently contributed to writing a book on Cannabis and its medical use.  I am currently the Director of Research & Innovation at Santé Canna bis clinic in Montréal where I lead the research department and direct pro jects for the advancement of cannabis-related Research.\n\nCaroline Lavoie \, Cannabis Consultant\, M.Sc.\n\nAs a consultant in the cannabis industry \, Caroline Lavoie advises Canadian and international companies from that sector in their government relations\, public relations and business devel opment. As one of Quebec’s first cannabis analyst and consultant\, Carolin e launched the public relations campaign that led to the creation of the S ociété Québécoise du cannabis (SQDC) and later led the formation of the Qu ebec Cannabis Industry Association (QCIA).  Prior to discovering her passi on for helping build the cannabis industry\, Caroline worked in internatio nal relations and public affairs in Canada\, the U.S.\, Latin America and Europe.  Caroline holds a Bachelor’s degree in political science and econo mics from McGill University and a Master’s in public policy from the Paris Institute for Political Studies (Sciences Po). A longtime volunteer with disadvantaged youth and cultural institutions in Montreal\, she also has a keen interest in governance and now acts as a Trustee for the Canadian Mu seum of Immigration at Pier 21 in Halifax.\n\nGuillaume Desparois\, MSc.\n Data Coordinator\, Sante Cannabis\n\nI completed my Masters degree in 2014 at the Université du Québec à Montréal (UQAM) in molecular biology\, test ing the effect of maternal obesity on the human placenta and materno-foeta l transfer of cholesterol.  I started my 4-year career in research working as a Research Assistant (and later as a Research Associate) in the R&D de partment of a private fertility clinic where I got experience on clinical trials\, recruitment of patients and Quality Control systems.  Starting to work at Santé Cannabis in late 2017\, it was not long before I got promot ed as Data Coordinator of the research department\, managing clinical tria ls’ build-up in the Clinical Data Management System (i.e. design of the st udy workflow and forms/questionnaires\, data surveillance\, database valid ation\, extraction\, etc.).\n\n \n\n\nRSVP through myFuture\n DTSTART:20191023T213000Z DTEND:20191023T230000Z LOCATION:Ballroom\, Thomson House\, CA\, QC\, Montreal\, H3A 1Y2\, 3650 rue McTavish SUMMARY:The Cannabis Panel URL:https://www.mcgill.ca/caps/channels/event/cannabis-panel-301097 END:VEVENT END:VCALENDAR